NASDAQ:XRAY - DENTSPLY SIRONA Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $64.00
Forecasted Upside: -0.11 %
Number of Analysts: 9
Breakdown:
1 Sell Ratings
3 Hold Ratings
5 Buy Ratings
0 Strong Buy Ratings

^$64.07 As of 06/23/2021 01:00 AM ET

▼ -0.29 (-0.45%)

1 month | 3 months | 12 months

Get New DENTSPLY SIRONA Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for XRAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XRAY

^$64.00

▼ -0.11% Downside Potential

This price target is based on 9 analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $64.00, with a high forecast of $78.00 and a low forecast of $47.00. The average price target represents a -0.11% upside from the last price of $64.07.

Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in DENTSPLY SIRONA. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
7 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

12/31/2019

0 strong buy ratings
5 buy ratings
4 hold ratings
1 sell ratings

Ratings as of

3/30/2020

0 strong buy ratings
6 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

6/28/2020

0 strong buy ratings
7 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

9/26/2020

0 strong buy ratings
8 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

12/25/2020

0 strong buy ratings
8 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

3/25/2021

0 strong buy ratings
6 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

5/24/2021

0 strong buy ratings
5 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

6/23/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/7/2021	Barrington Research	Boost Price Target	Outperform	$71.00 ➝ $77.00	Low
5/7/2021	Robert W. Baird	Boost Price Target	Outperform	$71.00 ➝ $78.00	Medium
5/7/2021	HC Wainwright	Boost Price Target	Neutral	$60.00 ➝ $72.00	Medium
5/6/2021	Piper Sandler	Boost Price Target	Overweight	$70.00 ➝ $75.00	Medium
3/2/2021	Barclays	Boost Price Target	Underweight	$50.00 ➝ $55.00	Medium
3/2/2021	Robert W. Baird	Boost Price Target	Outperform	$62.00 ➝ $71.00	Medium
3/2/2021	Barrington Research	Upgrade	Market Perform ➝ Outperform	$71.00	Medium
3/2/2021	HC Wainwright	Reiterated Rating	Neutral	$55.00 ➝ $60.00	Low
3/1/2021	Piper Sandler	Boost Price Target	Overweight	$63.00 ➝ $70.00	Low
1/5/2021	Robert W. Baird	Boost Price Target	Outperform	$58.00 ➝ $62.00	N/A
1/5/2021	Barclays	Boost Price Target	Underweight	$40.00 ➝ $44.00	N/A
1/5/2021	HC Wainwright	Boost Price Target	Neutral	$49.00 ➝ $55.00	N/A
12/18/2020	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$52.00	Low
12/15/2020	Piper Sandler	Boost Price Target	Overweight	$51.00 ➝ $61.00	High
11/17/2020	Barclays	Downgrade	Equal Weight ➝ Underweight	$40.00	Low
11/9/2020	HC Wainwright	Boost Price Target	Neutral	$45.00 ➝ $49.00	High
10/22/2020	Guggenheim	Upgrade	Neutral ➝ Buy		High
10/5/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$45.00 ➝ $47.00	Medium
8/10/2020	HC Wainwright	Lower Price Target	Neutral	$50.00 ➝ $45.00	Low
7/20/2020	Bank of America	Boost Price Target	Buy	$54.00 ➝ $56.00	Medium
6/16/2020	Piper Sandler	Initiated Coverage	Overweight	$51.00	Low
6/15/2020	HC Wainwright	Boost Price Target	Neutral	$38.00 ➝ $50.00	Medium
5/27/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform	$50.00	High
5/14/2020	Cfra	Lower Price Target	Hold	$53.00 ➝ $38.00	High
5/11/2020	Barclays	Lower Price Target	Equal Weight	$42.00 ➝ $40.00	High
5/11/2020	UBS Group	Lower Price Target	Neutral	$59.00 ➝ $44.00	High
5/11/2020	Barrington Research	Downgrade	Outperform ➝ Market Perform		Low
4/24/2020	HC Wainwright	Lower Price Target	Neutral	$51.00 ➝ $38.00	Medium
4/19/2020	Credit Suisse Group	Reiterated Rating	Buy	$50.00	Low
4/19/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform		Low
4/8/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$57.00 ➝ $49.00	Medium
4/7/2020	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$58.00 ➝ $40.00	Medium
4/2/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$66.00	Low
3/17/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$65.00 ➝ $45.00	High
3/13/2020	Stifel Nicolaus	Lower Price Target	Buy	$66.00 ➝ $56.00	Low
3/11/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Low
3/3/2020	Barrington Research	Lower Price Target	Outperform	$63.00 ➝ $60.00	Medium
3/3/2020	Robert W. Baird	Lower Price Target	Neutral	$61.00 ➝ $57.00	High
3/3/2020	HC Wainwright	Reiterated Rating	Neutral	$60.00 ➝ $51.00	High
2/19/2020	Stifel Nicolaus	Boost Price Target	Buy	$63.00 ➝ $66.00	Medium
1/19/2020	Barclays	Reiterated Rating	Hold	$64.00	Medium
12/11/2019	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$65.00	Low
11/15/2019	HC Wainwright	Reiterated Rating	Hold	$60.00	Low
8/5/2019	Barrington Research	Reiterated Rating	Buy	$63.00	High
8/2/2019	Wellington Shields	Upgrade	Hold ➝ Gradually Accumulate		High
7/26/2019	Evercore ISI	Initiated Coverage	In-line ➝ In-Line		Low
7/9/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$55.00 ➝ $57.00	Low
5/30/2019	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform		Low
5/6/2019	Barrington Research	Upgrade	Market Perform ➝ Outperform	$63.00	Medium
5/6/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$49.00 ➝ $55.00	Low
4/17/2019	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$54.00	High
4/5/2019	HC Wainwright	Set Price Target	Hold	$49.00	Low
3/18/2019	Bank of America	Initiated Coverage	Buy	$57.00	Low
3/18/2019	William Blair	Upgrade	Market Perform ➝ Outperform	$56.71	Medium
3/12/2019	UBS Group	Boost Price Target	Neutral ➝ Neutral	$42.00 ➝ $53.00	Low
3/4/2019	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$42.00 ➝ $50.00	Medium
3/4/2019	HC Wainwright	Reiterated Rating	Neutral ➝ Neutral	$40.00 ➝ $49.00	Low
3/1/2019	William Blair	Upgrade	Market Perform ➝ Outperform		Low
3/1/2019	Barclays	Set Price Target	Hold	$49.00	Low
1/17/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$42.00	Low
1/6/2019	Barclays	Reiterated Rating	Hold	$39.00	Medium
11/9/2018	Barrington Research	Reiterated Rating	Hold		Medium
10/19/2018	The Goldman Sachs Group	Upgrade	Sell ➝ Buy	$44.00	High
8/31/2018	HC Wainwright	Set Price Target	Hold	$40.00	Medium
8/9/2018	Barrington Research	Downgrade	Outperform ➝ Market Perform		Low
8/8/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$55.00 ➝ $41.00	Medium
8/8/2018	Jefferies Financial Group	Lower Price Target	Buy ➝ Buy	$58.00 ➝ $46.00	Medium
8/8/2018	Stifel Nicolaus	Lower Price Target	Buy ➝ Buy	$57.00 ➝ $46.00	Medium
8/8/2018	HC Wainwright	Reiterated Rating	Hold	$40.00	Medium
8/8/2018	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$54.00 ➝ $40.00	Medium
8/8/2018	Stephens	Downgrade	Overweight ➝ Equal Weight	$75.00	Medium
8/7/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$56.00 ➝ $38.00	High
6/14/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$65.00 ➝ $54.00	Low
6/5/2018	Northcoast Research	Downgrade	Buy ➝ Neutral		High
5/16/2018	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$55.00	Low
5/8/2018	Robert W. Baird	Lower Price Target	Outperform ➝ Outperform	$71.00	High
5/8/2018	Barrington Research	Lower Price Target	Outperform ➝ Outperform	$70.00 ➝ $54.00	High
5/8/2018	Barclays	Reiterated Rating	Hold	$55.00	High
5/8/2018	Stifel Nicolaus	Reiterated Rating	Buy ➝ Buy	$67.00 ➝ $57.00	High
5/8/2018	HC Wainwright	Lower Price Target	Neutral ➝ Neutral	$63.00 ➝ $52.00	High
4/16/2018	Jefferies Financial Group	Reiterated Rating	Buy		Low
4/5/2018	Cleveland Research	Reiterated Rating	Hold		Low
3/27/2018	Barrington Research	Reiterated Rating	Buy	$69.00	Medium
3/27/2018	HC Wainwright	Set Price Target	Hold	$63.00	Medium
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$62.00	Low
3/5/2018	JPMorgan Chase & Co.	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $70.00	Low
3/5/2018	Barrington Research	Reiterated Rating	Outperform ➝ Outperform	$73.00 ➝ $70.00	Low
3/5/2018	HC Wainwright	Set Price Target	Neutral ➝ Hold	$68.00 ➝ $63.00	Medium
3/2/2018	Credit Suisse Group	Lower Price Target	Outperform ➝ Outperform	$73.00 ➝ $69.00	High
1/18/2018	HC Wainwright	Reiterated Rating	Hold	$68.00	Low
1/5/2018	Credit Suisse Group	Downgrade	Hold	$73.00	Medium
12/13/2017	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$75.00	Medium
12/8/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$81.00	Low
12/7/2017	HC Wainwright	Reiterated Rating	Hold	$68.00	Low
11/30/2017	HC Wainwright	Downgrade	Buy ➝ Neutral	$68.00	Medium
11/28/2017	Stephens	Initiated Coverage	Overweight	$75.00	Low
11/6/2017	Stifel Nicolaus	Boost Price Target	Buy	$66.00 ➝ $70.00	N/A
11/6/2017	HC Wainwright	Reiterated Rating	Buy	$68.00	N/A
11/6/2017	Barrington Research	Upgrade	Market Perform ➝ Outperform	$73.00	N/A
10/19/2017	Robert W. Baird	Set Price Target	Buy	$63.00	N/A
10/19/2017	Stifel Nicolaus	Reiterated Rating	Buy		N/A
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$67.00 ➝ $69.00	N/A
10/5/2017	Cleveland Research	Downgrade	Buy ➝ Neutral		N/A
10/3/2017	HC Wainwright	Reiterated Rating	Buy	$68.00	Low
8/23/2017	Jefferies Financial Group	Lower Price Target	Buy	$72.00 ➝ $66.00	High
8/14/2017	HC Wainwright	Reiterated Rating	Buy ➝ Buy	$74.00 ➝ $68.00	Medium
8/10/2017	UBS Group	Reiterated Rating	Neutral	$62.00 ➝ $59.00	Low
8/10/2017	Morgan Stanley	Boost Price Target	Overweight	$66.00 ➝ $67.00	Low
8/10/2017	Stifel Nicolaus	Reiterated Rating	Buy	$70.00 ➝ $66.00	Low
7/13/2017	Credit Suisse Group	Reiterated Rating	Outperform	$67.00 ➝ $75.00	Low
7/11/2017	HC Wainwright	Initiated Coverage	Buy ➝ Buy	$74.00	Low
5/23/2017	Cleveland Research	Upgrade	Neutral ➝ Buy		Medium
5/23/2017	The Goldman Sachs Group	Downgrade	Neutral ➝ Sell	$60.00 ➝ $55.00	Medium
2/21/2017	Barrington Research	Downgrade	Outperform ➝ Market Perform		N/A
2/13/2017	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$62.00 ➝ $70.00	N/A
1/23/2017	Jefferies Financial Group	Lower Price Target	Buy	$70.00 ➝ $68.00	N/A
12/5/2016	Barrington Research	Upgrade	Market Perform ➝ Outperform	$63.00	N/A
11/7/2016	UBS Group	Reiterated Rating	Neutral	$64.00 ➝ $67.00	N/A
11/1/2016	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$65.00 ➝ $69.00	N/A
10/4/2016	Robert W. Baird	Reiterated Rating	Outperform	$69.00 ➝ $67.00	N/A
9/22/2016	JPMorgan Chase & Co.	Initiated Coverage	Neutral	$65.00	N/A
9/12/2016	Bank of America	Initiated Coverage	Buy	$70.00	N/A
8/17/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A
8/8/2016	Barrington Research	Downgrade	Outperform ➝ Market Perform		N/A
6/28/2016	UBS Group	Reiterated Rating	Hold		N/A
6/27/2016	Piper Jaffray Companies	Reiterated Rating	Buy		N/A
6/26/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A

(Data available from 6/23/2016 forward)

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.

Today's Range

Now: $64.07

$63.10

$64.86

50 Day Range

MA: $66.43

$63.18

$69.12

52 Week Range

Now: $64.07

$40.15

$69.54

Volume

1,708,817 shs

Average Volume

1,576,705 shs

Market Capitalization

$13.99 billion

P/E Ratio

81.10

Dividend Yield

0.62%

Beta

0.93

Frequently Asked Questions

What sell-side analysts currently cover shares of DENTSPLY SIRONA?

The following Wall Street research analysts have issued research reports on DENTSPLY SIRONA in the last twelve months: Bank of America Co., Barclays PLC, Barrington Research, Guggenheim, HC Wainwright, JPMorgan Chase & Co., Piper Sandler, Robert W. Baird, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for XRAY.

What is the current price target for DENTSPLY SIRONA?

8 Wall Street analysts have set twelve-month price targets for DENTSPLY SIRONA in the last year. Their average twelve-month price target is $64.00, suggesting a possible downside of 0.1%. Robert W. Baird has the highest price target set, predicting XRAY will reach $78.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $47.00 for DENTSPLY SIRONA in the next year.
View the latest price targets for XRAY.

What is the current consensus analyst rating for DENTSPLY SIRONA?

DENTSPLY SIRONA currently has 1 sell rating, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XRAY, but not buy more shares or sell existing shares.
View the latest ratings for XRAY.

What other companies compete with DENTSPLY SIRONA?

Other companies that are similar to DENTSPLY SIRONA include Align Technology, West Pharmaceutical Services, The Cooper Companies, STAAR Surgical, Neogen, Quidel, ICU Medical, Merit Medical Systems, Haemonetics, Atrion, Cerus, Meridian Bioscience, Antares Pharma, OraSure Technologies and Anika Therapeutics.

How do I contact DENTSPLY SIRONA's investor relations team?

DENTSPLY SIRONA's physical mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier's listed phone number is 844-546-3722 and its investor relations email address is [email protected] The official website for DENTSPLY SIRONA is www.dentsplysirona.com.